National Essential Medicine List Committee (NEMLC) rapid reviews of the evidence for numerous proposed treatment options for COVID-19 disease.

The Committee has evaluated evidence reviews for:

  • Remdesivir

  • Hydroxychloroquine/ chloroquine

  • IV Immunoglobulin

  • Interferons

  • Tocilizumab

  • Lopinavir/ Ritonavir

The conclusion is that for ALL independently reviewed treatments there is insufficient evidence for inclusion in any treatment guidelines / regimens at present.

There are however ongoing trials and information will be updated accordingly.

Did this answer your question?